HPV vaccine study in primary care
Part of Infections clinical trials.
This study helps make sure kids get the HPV vaccine during routine checkups. It is for children who have not yet had any dose of the HPV vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at a participating doctor's office.
- You are coming in for a regular well-child visit during the study period.
- You have never received a dose of the HPV vaccine before.
- You are in the age range recommended for the HPV vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether training pharmacy staff in communication and vaccination workflows can improve HPV vaccine recommendations and uptake. If you are a parent or guardian of a child aged 9–17 who has not yet completed the HPV vaccine series, you may be eligible to participate.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
This trial tests whether an HPV vaccine (the nonavalent type) can help prevent the same precancerous lesions from coming back after treatment. It is for people who currently have a high-grade HPV-related lesion but have not yet been treated for it.
This trial tests a program at school health centers to help teens get their HPV vaccine and learn about wellness. If you're due for the HPV shot, this could be a helpful way to get it in a familiar place.
This study tests whether real-time reminders and guidance help families stay on track with the HPV vaccine for children who are 11–12 years old. It’s a “feasibility” study, meaning it focuses on whether the approach is practical and acceptable.
Hear when a new Human Papilloma Virus Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.